nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA2C—GPCR downstream signaling—CCR6—Crohn's disease	0.00132	0.00132	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RSPO3—Crohn's disease	0.00132	0.00132	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ITGA4—Crohn's disease	0.00131	0.00131	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CCR6—Crohn's disease	0.0013	0.0013	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CCR6—Crohn's disease	0.00129	0.00129	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00128	0.00128	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IL3—Crohn's disease	0.00127	0.00127	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR9—Crohn's disease	0.00127	0.00127	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MLN—Crohn's disease	0.00126	0.00126	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PTGER4—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SEL1L—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Phentolamine—ADRA2C—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	0.00124	0.00124	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RSPO3—Crohn's disease	0.00124	0.00124	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	0.00123	0.00123	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RSPO3—Crohn's disease	0.00122	0.00122	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCR6—Crohn's disease	0.0012	0.0012	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCR6—Crohn's disease	0.00118	0.00118	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GPR65—Crohn's disease	0.00118	0.00118	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IL2RA—Crohn's disease	0.00118	0.00118	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—IL3—Crohn's disease	0.00118	0.00118	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00117	0.00117	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SEL1L—Crohn's disease	0.00117	0.00117	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTMR3—Crohn's disease	0.00117	0.00117	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SEL1L—Crohn's disease	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR9—Crohn's disease	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00115	0.00115	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00114	0.00114	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PTGER4—Crohn's disease	0.00113	0.00113	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—FADS1—Crohn's disease	0.00112	0.00112	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IL2RA—Crohn's disease	0.0011	0.0011	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	0.00108	0.00108	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.00107	0.00107	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR9—Crohn's disease	0.00107	0.00107	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL3—Crohn's disease	0.00107	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GPR65—Crohn's disease	0.00107	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL3—Crohn's disease	0.00106	0.00106	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00106	0.00106	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PTGER4—Crohn's disease	0.00106	0.00106	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR9—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GPX4—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PTGER4—Crohn's disease	0.00104	0.00104	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—RASGRP1—Crohn's disease	0.00103	0.00103	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00103	0.00103	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GCKR—Crohn's disease	0.00101	0.00101	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00101	0.00101	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	0.001	0.001	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GPR65—Crohn's disease	0.000996	0.000996	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL3—Crohn's disease	0.000992	0.000992	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00099	0.00099	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GPR65—Crohn's disease	0.00098	0.00098	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL3—Crohn's disease	0.000976	0.000976	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000976	0.000976	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000975	0.000975	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL3—Crohn's disease	0.000964	0.000964	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000959	0.000959	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.000951	0.000951	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000946	0.000946	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000944	0.000944	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.000936	0.000936	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000933	0.000933	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000924	0.000924	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000909	0.000909	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL3—Crohn's disease	0.000901	0.000901	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—CXCL8—Crohn's disease	0.000894	0.000894	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.000893	0.000893	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000891	0.000891	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL3—Crohn's disease	0.000886	0.000886	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.000871	0.000871	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.000871	0.000871	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.00087	0.00087	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.000867	0.000867	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000866	0.000866	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000859	0.000859	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000857	0.000857	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GPX4—Crohn's disease	0.000852	0.000852	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—ALB—Crohn's disease	0.000851	0.000851	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR6—Crohn's disease	0.000841	0.000841	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000839	0.000839	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—IL2RA—Crohn's disease	0.000824	0.000824	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GCKR—Crohn's disease	0.000823	0.000823	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.000809	0.000809	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—CXCL8—Crohn's disease	0.000807	0.000807	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.000806	0.000806	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000805	0.000805	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—ALB—Crohn's disease	0.000795	0.000795	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—JAK2—Crohn's disease	0.000791	0.000791	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.000787	0.000787	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000779	0.000779	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000762	0.000762	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RBX1—Crohn's disease	0.000761	0.000761	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR6—Crohn's disease	0.00076	0.00076	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	0.000754	0.000754	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL2RA—Crohn's disease	0.000748	0.000748	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000744	0.000744	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	0.000742	0.000742	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	0.000741	0.000741	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000739	0.000739	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—JAK2—Crohn's disease	0.000739	0.000739	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000732	0.000732	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	0.00071	0.00071	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000708	0.000708	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	0.000698	0.000698	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000695	0.000695	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	0.000687	0.000687	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000684	0.000684	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000675	0.000675	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	0.000669	0.000669	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	0.000667	0.000667	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000659	0.000659	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000657	0.000657	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	0.000647	0.000647	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ALB—Crohn's disease	0.000646	0.000646	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	0.000642	0.000642	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	0.000632	0.000632	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000631	0.000631	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL3—Crohn's disease	0.000631	0.000631	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	0.000625	0.000625	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000621	0.000621	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.00062	0.00062	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	0.000615	0.000615	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000613	0.000613	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	0.00061	0.00061	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000607	0.000607	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000602	0.000602	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—JAK2—Crohn's disease	0.0006	0.0006	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	0.000584	0.000584	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	0.000576	0.000576	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL3—Crohn's disease	0.00057	0.00057	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000564	0.000564	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000563	0.000563	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000561	0.000561	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000554	0.000554	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	0.000554	0.000554	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	0.000553	0.000553	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000552	0.000552	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000551	0.000551	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000546	0.000546	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	0.000546	0.000546	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	0.000537	0.000537	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL3—Crohn's disease	0.000532	0.000532	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	0.000527	0.000527	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	0.000524	0.000524	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.000521	0.000521	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000515	0.000515	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000513	0.000513	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000507	0.000507	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000507	0.000507	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000505	0.000505	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	0.000503	0.000503	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.0005	0.0005	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	0.000499	0.000499	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000492	0.000492	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.000477	0.000477	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000477	0.000477	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000476	0.000476	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000467	0.000467	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	0.000466	0.000466	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000465	0.000465	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.00046	0.00046	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000459	0.000459	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.000459	0.000459	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000457	0.000457	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000456	0.000456	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000454	0.000454	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.00045	0.00045	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	0.000445	0.000445	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000443	0.000443	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.000442	0.000442	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	0.000438	0.000438	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	0.000432	0.000432	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000431	0.000431	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000426	0.000426	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	0.000424	0.000424	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000419	0.000419	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000418	0.000418	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	0.000417	0.000417	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000414	0.000414	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000408	0.000408	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000408	0.000408	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	0.000403	0.000403	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	0.000399	0.000399	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	0.000396	0.000396	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000389	0.000389	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000387	0.000387	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000381	0.000381	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000379	0.000379	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000379	0.000379	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	0.000373	0.000373	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000373	0.000373	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000371	0.000371	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	0.000367	0.000367	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	0.000361	0.000361	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.000352	0.000352	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000346	0.000346	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	0.000344	0.000344	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000338	0.000338	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	0.000327	0.000327	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	0.000326	0.000326	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—Crohn's disease	0.000322	0.000322	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000314	0.000314	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	0.000311	0.000311	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	0.000303	0.000303	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	0.000297	0.000297	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—Crohn's disease	0.000282	0.000282	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	0.000281	0.000281	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	0.000271	0.000271	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	0.000268	0.000268	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	0.000263	0.000263	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—Crohn's disease	0.000262	0.000262	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	0.000258	0.000258	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	0.000258	0.000258	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	0.000251	0.000251	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	0.000247	0.000247	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	0.000245	0.000245	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	0.000233	0.000233	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	0.00023	0.00023	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—Crohn's disease	0.000229	0.000229	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	0.000229	0.000229	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	0.000225	0.000225	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	0.000219	0.000219	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	0.000218	0.000218	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	0.000217	0.000217	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	0.000214	0.000214	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	0.000213	0.000213	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	0.000203	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	0.0002	0.0002	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	0.000197	0.000197	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	0.00019	0.00019	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	0.000186	0.000186	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	0.000184	0.000184	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	0.000181	0.000181	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	0.000177	0.000177	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	0.000161	0.000161	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	0.000152	0.000152	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	0.000149	0.000149	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	0.000138	0.000138	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	0.000128	0.000128	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	0.000126	0.000126	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	0.000112	0.000112	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	0.000104	0.000104	CbGpPWpGaD
